Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R McCurdy

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Pharmacological Reports : PR|February 8, 2026
The Sigma<sub>1</sub> receptor antagonist CM304 potentiates the antinociceptive effects of the cannabinoid receptor agonist delta<sup>9</sup>-tetrahydrocannabinol in rats and miceElmira Zolali, Mallory Burns, Sebastiano Intagliata, et al.
Drug and Alcohol Dependence|October 5, 2020
Lyophilized Kratom Tea as a Therapeutic Option for Opioid DependenceLisa L Wilson, Hannah M Harris, Shainnel O Eans, et al.
EJNMMI Research|September 19, 2015
Further validation to support clinical translation of [(18)F]FTC-146 for imaging sigma-1 receptorsBin Shen, Michelle L James, Lauren Andrews, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2013
Evaluation of σ-1 receptor radioligand 18F-FTC-146 in rats and squirrel monkeys using PETMichelle L James, Bin Shen, Carsten H Nielsen, et al.
Theranostics|July 30, 2020
Evaluation of <sup>18</sup>F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration <i>in vivo</i> in rodents and in human tissueFrançois-Xavier Lepelletier, Matthias Vandesquille, Marie-Claude Asselin, et al.
Theranostics|August 22, 2017
Visualizing Nerve Injury in a Neuropathic Pain Model with [<sup>18</sup>F]FTC-146 PET/MRIBin Shen, Deepak Behera, Michelle L James, et al.
Psychopharmacology|June 2, 2017
Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in ratsE Andrew Townsend, Jennifer E Naylor, S Stevens Negus, et al.
Theranostics|August 1, 2022
Erratum: Evaluation of <sup>18</sup>F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration <i>in vivo</i> in rodents and in human tissue: ErratumFrançois-Xavier Lepelletier, Matthias Vandesquille, Marie-Claude Asselin, et al.
Pathogens (Basel, Switzerland)|November 27, 2021
Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected CellsDavid A Ostrov, Andrew P Bluhm, Danmeng Li, et al.
Drug and Alcohol Dependence Reports|July 3, 2023
Kratom withdrawal: Discussions and conclusions of a scientific expert forumJack E Henningfield, Marek C Chawarski, Albert Garcia-Romeu, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Pharmacological Reports : PR|February 8, 2026
The Sigma<sub>1</sub> receptor antagonist CM304 potentiates the antinociceptive effects of the cannabinoid receptor agonist delta<sup>9</sup>-tetrahydrocannabinol in rats and miceElmira Zolali, Mallory Burns, Sebastiano Intagliata, et al.
Drug and Alcohol Dependence|October 5, 2020
Lyophilized Kratom Tea as a Therapeutic Option for Opioid DependenceLisa L Wilson, Hannah M Harris, Shainnel O Eans, et al.
EJNMMI Research|September 19, 2015
Further validation to support clinical translation of [(18)F]FTC-146 for imaging sigma-1 receptorsBin Shen, Michelle L James, Lauren Andrews, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2013
Evaluation of σ-1 receptor radioligand 18F-FTC-146 in rats and squirrel monkeys using PETMichelle L James, Bin Shen, Carsten H Nielsen, et al.
Theranostics|July 30, 2020
Evaluation of <sup>18</sup>F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration <i>in vivo</i> in rodents and in human tissueFrançois-Xavier Lepelletier, Matthias Vandesquille, Marie-Claude Asselin, et al.
Theranostics|August 22, 2017
Visualizing Nerve Injury in a Neuropathic Pain Model with [<sup>18</sup>F]FTC-146 PET/MRIBin Shen, Deepak Behera, Michelle L James, et al.
Psychopharmacology|June 2, 2017
Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in ratsE Andrew Townsend, Jennifer E Naylor, S Stevens Negus, et al.
Theranostics|August 1, 2022
Erratum: Evaluation of <sup>18</sup>F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration <i>in vivo</i> in rodents and in human tissue: ErratumFrançois-Xavier Lepelletier, Matthias Vandesquille, Marie-Claude Asselin, et al.
Pathogens (Basel, Switzerland)|November 27, 2021
Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected CellsDavid A Ostrov, Andrew P Bluhm, Danmeng Li, et al.
Drug and Alcohol Dependence Reports|July 3, 2023
Kratom withdrawal: Discussions and conclusions of a scientific expert forumJack E Henningfield, Marek C Chawarski, Albert Garcia-Romeu, et al.
Pageof 22